Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Saturday, February 24, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - TUESDAY, MAY 10TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 32151.38 -94.32 (-0.29%) | NASDAQ 11642.73 19.48 (0.17%) | S&P 500 3983.32 -7.92 (-0.20%)
Time of Screening : 5/10/2022 12:19:54 PM         Report Released : 5/10/2022 1:59:00 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 50% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page


NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.


Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
AFG - NYSE - INSURANCE - Property & Casualty Insurance
American Financial Group
$142.52 -1.68
-1.17%
$146.00 $152.29 -6.42% 168,901
53.79%
314,000
Most Recent Note for AFG - 5/10/2022 12:22:51 PM
Perched near its all-time high. Reported strong results in recent quarterly comparisons through Mar '22 versus the year ago periods but with lackluster sales revenues growth. Annual earnings (A criteria) had a downturn in FY '20, not a match with the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
BECN - NASDAQ - MATERIALS &; CONSTRUCTION - General Building Materials
Beacon Roofing Supply
$59.99 -1.92
-3.09%
$62.56 $64.90 -7.57% 261,682
66.76%
392,000
Most Recent Note for BECN - 5/10/2022 12:25:02 PM
Pulling back with volume-driven losses this week after hitting a new 52-week high and challenging its all-time high when the 5/06/22 mid-day report noted - "Reported earnings +326% on +28% sales revenues for the Mar '22 quarter versus the year ago period, and prior quarterly comparisons were well above the +25% minimum guideline (C criteria). Up and down annual earnings is a flaw concerning the A criteria of the fact-based investment system's guidelines. Completed a Secondary Offering on 5/18/16."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CAPL - NYSE - Oil&Gas-Refining/Mktg
CrossAmerica Partners LP
$19.99 +0.24
1.22%
$21.17 $23.29 -14.17% 35,349
78.55%
45,000
Most Recent Note for CAPL - 5/10/2022 12:28:04 PM
Slumped from its 52-week high and violated its 50 and 200 DMA lines since the 4/12/22 mid-day last report noted - "Fundamental concerns remain."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
CPSS - NASDAQ - FINANCIAL SERVICES - Credit Services
Consumer Portfolio Svcs
$14.13 -0.96
-6.36%
$15.00 $14.77 -4.33% 107,831
86.96%
124,000
Most Recent Note for CPSS - 5/10/2022 12:29:02 PM
Hit a new 52-week high on the prior session with its 6th consecutive volume-driven gain. Quarterly earnings increases were strong in Dec '21 and Mar '22 versus year ago periods. Prior history is not a match with the fact-based investment system's guidelines (A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
DOW - NYSE - Chemicals-Plastics
Dow Inc
$66.06 -0.57
-0.86%
$67.85 $71.86 -8.07% 3,055,215
54.61%
5,595,000
Most Recent Note for DOW - 5/10/2022 12:31:45 PM
It formed a long saucer-with-handle base over the past year. The 5/02/22 mid-day report last noted - "Reported strong sales revenues and earnings increases in quarterly comparisons through Mar '22 versus the year ago periods. Annual earnings (A criteria) history has not been strong and steady."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
EOG - NYSE - Oil&Gas-U S Expl&Prod
E O G Resources Inc
$119.66 +1.72
1.46%
$125.06 $132.35 -9.59% 2,415,666
52.11%
4,636,000
Most Recent Note for EOG - 5/10/2022 12:34:01 PM
Abruptly retreated again after hitting a new 52-week high with a big gain noted on 5/06/22, showing resilience and strength after briefly undercutting its 50 DMA line. Reported Mar '22 quarterly earnings +147% on +8% sales revenues over the year ago period. Showed solid earnings and much larger sales revenues increases for the Jun, Sep, and Dec '21 quarters versus the year ago periods. Fundamental concerns remain. Erratic annual earnings (A criteria) history is cause for concern.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
FMAO - NASDAQ - Banks-Midwest
Farmers & Merchants Banc
$36.02 -2.63
-6.79%
$38.99 $41.64 -13.51% 34,045
109.82%
31,000
Most Recent Note for FMAO - 5/10/2022 12:36:12 PM
Abruptly retreating below its 50 DMA line with today's loss after getting extended from any sound base. Three of the past 4 quarterly comparisons through Mar '22 showed earnings above the +25% minimum guideline (C criteria). Prior history is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GPK - NYSE - CONSUMER NON-DURABLES - Packaging & Containers
Graphic Packaging Hldg
$20.86 -0.25
-1.16%
$21.60 $22.71 -8.17% 1,458,640
53.06%
2,749,000
Most Recent Note for GPK - 5/10/2022 12:38:17 PM
Encountered distributional pressure in recent weeks. Reported earnings +87% on +36% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly and annual earnings history is not a great match with the fact-based investment system's fundamental guidelines (C and A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
GSK - NYSE - Medical-Diversified
Glaxosmithkline Plc Adr
$43.32 +0.16
0.37%
$43.63 $46.97 -7.77% 3,946,474
79.41%
4,970,000
Most Recent Note for GSK - 5/10/2022 12:41:25 PM
UK-based pharmaceuticals firm's quarterly comparisons through Mar '22 have not shown strong and steady earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HPE - NYSE - Computer- Tech Services
Hewlett Packard Ent Co
$16.00 +0.16
0.98%
$16.23 $17.76 -9.94% 6,700,839
61.53%
10,891,000
Most Recent Note for HPE - 5/10/2022 12:44:31 PM
Recently found support while consolidating near its 200 DMA line. Sales revenues growth has been lackluster and earnings history is not a match with the fact-based investment system's guidelines (C and A criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HSY - NYSE - FOOD & BEVERAGE - Confectioners
Hershey Company
$223.91 +0.71
0.32%
$225.87 $231.60 -3.32% 549,568
50.56%
1,087,000
Most Recent Note for HSY - 5/10/2022 12:45:57 PM
Perched near its all-time high, extended from any sound base. Fundamental concerns remain. Reported earnings +32% on +16% sales revenues for the Mar '22 quarter versus the year ago period. Prior quarterly comparisons showed sub par sales and earnings increases below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history has been slow and steady.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
HURN - NASDAQ - DIVERSIFIED SERVICES - Business/Management Services
Huron Consulting Grp Inc
$54.77 +0.32
0.59%
$55.55 $57.60 -4.91% 67,940
56.15%
121,000
Most Recent Note for HURN - 5/10/2022 12:50:38 PM
Hovering near its 52-week high, perched within striking distance of multi-year highs. Reported earnings +40% on +29% sales revenues for the quarter ended March 31, 2022 versus the year ago period, its 3rd consecutive quarterly comparison above the +25% minimum earnings guideline (C criteria). Up and down annual earnings (A criteria) history is not a good match with the guidelines of the fact-based system. It survived but failed to impress since dropped from the Featured Stocks list on 8/15/2007.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$106.74 +0.49
0.46%
$109.15 $122.16 -12.63% 755,717
50.79%
1,488,000
Most Recent Note for NVO - 5/10/2022 12:56:11 PM
This Denmark-based Medical - Ethical Drug firm violated its 50 DMA line ($110.60) as it gapped down on the prior session testing its 200 DMA line ($105) with volume-driven losses. Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$106.74 +0.49
0.46%
$109.15 $122.16 -12.63% 755,717
50.79%
1,488,000
Most Recent Note for NVO - 5/10/2022 12:54:53 PM
This Denmark-based Medical - Ethical Drug firm violated its 50 DMA line ($110.60) as it gapped down on the prior session testing its 200 DMA line ($105) with volume-driven losses. Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$106.74 +0.49
0.46%
$109.15 $122.16 -12.63% 755,717
50.79%
1,488,000
Most Recent Note for NVO - 5/10/2022 12:54:10 PM
This Denmark-based Medical - Ethical Drug firm violated its 50 DMA line ($110.60) as it gapped down on the prior session testing its 200 DMA line ($105) with volume-driven losses. Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
NVO - NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
$106.74 +0.49
0.46%
$109.15 $122.16 -12.63% 755,717
50.79%
1,488,000
Most Recent Note for NVO - 5/10/2022 12:53:19 PM
This Denmark-based Medical - Ethical Drug firm violated its 50 DMA line ($110.60) as it gapped down on the prior session testing its 200 DMA line ($105) with volume-driven losses. Fundamental concerns remain after it reported Mar '22 quarterly earnings +8% on +17% sales revenues versus the year ago period.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PBH - NYSE - CONSUMER NON-DURABLES - Personal Products
Prestige Brands Holdings
$57.70 +0.25
0.44%
$58.77 $63.83 -9.60% 177,120
66.84%
265,000
Most Recent Note for PBH - 5/10/2022 1:41:14 PM
Rebounding near its 200 DMA line. The 2/04/22 mid-day report noted - "Reported Mar '22 quarterly earnings +22% on +15% sales revenues versus the year ago period. Prior quarterly comparisons have not shown strong and steady earnings above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PNNT - NASDAQ - Finance-Investment Mgmt
Pennantpark Investment
$7.10 +0.02
0.28%
$7.23 $8.02 -11.47% 213,473
65.89%
324,000
Most Recent Note for PNNT - 5/10/2022 1:41:44 PM
Slumping well below its 50 DMA line ($7.68) toward its 200 DMA line ($7.04). Reported strong Sep, Dec '21, and Mar '22 quarterly results versus the year ago periods. Prior quarterly and annual earnings history is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PRGS - NASDAQ - COMPUTER SOFTWARE & SERVICES - Application Software
Progress Software Corp
$45.94 +0.29
0.64%
$46.72 $53.99 -14.91% 245,484
77.68%
316,000
Most Recent Note for PRGS - 5/10/2022 1:43:01 PM
Reported earnings +2% on +19% sales revenues for the quarter ended Feb 28, 2022 versus the year ago period, its 2nd consecutive quarterly comparison below the +25% minimum earnings guideline (C criteria) of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
PXD - NYSE - ENERGY - Independent Oil & Gas
Pioneer Natural Resource
$248.20 +3.81
1.56%
$257.90 $272.47 -8.91% 1,302,683
52.09%
2,501,000
Most Recent Note for PXD - 5/10/2022 1:43:58 PM
Pulled back from its 52-week high testing its 50 DMA line ($244). Reported Mar '22 quarterly earnings +337% on +153% versus the year ago period. Completed a Secondary Offering on 5/12/21. Fundamental concerns remain. Annual earnings (A criteria) history had a downturn in FY '20, not a match with the fact-based investment system's guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
SAMG - NASDAQ - Finance-Investment Mgmt
Silvercrest Asset Cl A
$19.97 -0.30
-1.48%
$20.70 $22.68 -11.95% 29,739
78.26%
38,000
Most Recent Note for SAMG - 5/10/2022 1:45:57 PM
Pulling back below its 50 DMA line ($20.13). Reported Mar '22 quarterly earnings +7% on +7% sales revenues versus the year ago period. Prior 3 quarterly earnings increases versus the year ago period were above the +25% minimum guideline (C criteria). Annual earnings (A criteria) history had a downturn in FY '19, not strong and steady.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
THFF - NASDAQ - BANKING - Regional - Midwest Banks
First Financial Corp Ind
$43.15 -0.74
-1.69%
$44.20 $47.10 -8.39% 156,362
226.61%
69,000
Most Recent Note for THFF - 5/10/2022 1:47:08 PM
Slumping below its 200 DMA line with today's volume-driven loss. Reported strong Mar '22 quarterly results. Prior quarterly earnings increases were not strong and steady above the +25% minimum guideline (C criteria).
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
TS - NYSE - METALS & MINING - Steel & Iron
Tenaris Sa Adr
$29.37 +0.37
1.28%
$29.96 $33.28 -11.75% 1,484,020
51.05%
2,907,000
Most Recent Note for TS - 5/10/2022 1:49:13 PM
Slumped below its 50 DMA line with a volume-driven loss on the prior session when noted with caution in the mid-day report -"Recent quarterly comparisons through Mar '22 showed very strong sales revenues and earnings increases over the year ago periods. Annual earnings history is not a match with the fundamental guidelines of the fact-based investment system."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
UNTY - NASDAQ - BANKING - Regional - Northeast Banks
Unity Bancorp Inc
$28.04 -0.25
-0.88%
$28.25 $31.37 -10.62% 17,760
57.29%
31,000
Most Recent Note for UNTY - 5/10/2022 1:51:39 PM
Sputtering below its 50 DMA line today following volume-driven losses. Fundamental concerns remain. Reported Mar '22 quarterly earnings +6% on -4% sales revenues versus the year ago period, below the +25% minimum guideline (C criteria). Sub par sales revenues growth remains a concern. Annual earnings steadily improved after a downturn in FY '17.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VNOM - NASDAQ - Oil&Gas-U S Expl&Prod
Viper Energy Partners Lp
$28.76 +0.83
2.97%
$29.73 $32.35 -11.10% 271,549
51.82%
524,000
Most Recent Note for VNOM - 5/10/2022 1:55:39 PM
This Oil & Gas - US Exploration & Production LP violated its 50 DMA line ($29.88) with a big volume-driven loss on the prior session. Quarterly comparisons through Mar '22 showed strong sales revenues and earnings increases versus year ago periods. Annual earnings (A criteria) history has been sub par. Since its $26 IPO in June 2014 it completed additional new Public Offerings in Sep '14, Jul '16, Jan '17, Jul '17, and Jul '18.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
VWTR - NASDAQ - Utility-Water Supply
Vidler Water Resources
$15.62 -0.04
-0.26%
$15.70 $17.24 -9.40% 121,656
54.80%
222,000
Most Recent Note for VWTR - 5/10/2022 1:55:55 PM
Holding its ground following 4/14/22 M&A news with D.R. Horton Inc (DHI). Prior mid-day reports repeatedly noted - "Reported strong Dec '21 quarterly results but its prior earnings history is not a match with the fact-based investment system's fundamental guidelines (C and A criteria)."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
WMB - NYSE - ENERGY - Oil & Gas Pipelines
Williams Companies
$33.98 -0.76
-2.19%
$35.27 $37.05 -8.29% 4,815,498
53.95%
8,926,000
Most Recent Note for WMB - 5/10/2022 1:57:30 PM
Pulled back from its 52-week high testing its 50 DMA line ($33.73) with today's loss. Reported Mar '22 quarterly earnings +17% on -3% sales revenues versus the year ago period. Its annual and quarterly earnings history has been up and down, not a match with the investment system's C and A criteria.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
XOM - NYSE - ENERGY - Major Integrated Oil & Gas
Exxon Mobil Corp
$84.44 -0.02
-0.02%
$86.89 $92.05 -8.27% 16,112,823
50.14%
32,135,000
Most Recent Note for XOM - 5/10/2022 1:58:52 PM
Pulled back on the prior session with a big volume-driven loss retreating from new multi-year highs. Recent quarterly comparisons through Mar '22 showed strong sales revenues and earnings increases over the year ago periods. Annual earnings (A criteria) history has been erratic.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us